10-Feb-2023
Download PDF
Laurus Labs
This is to inform you that the United States Food & Drug Administration (USFDA) today completed inspection of our formulations manufacturing facility Unit-2 APSEZ Atchutapuram Visakhapatnam Andhra Pradesh. The inspection was conducted from 6th February 2023 to 10th February 2023. We have been issued a Form 483 with two observations. The observations are procedural in nature. The Company will address the observations within stipulated timelines.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
